{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T15:33:17Z","timestamp":1779377597597,"version":"3.53.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T00:00:00Z","timestamp":1741737600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T00:00:00Z","timestamp":1741737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82260159;81860146"],"award-info":[{"award-number":["82260159;81860146"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-93522-3","type":"journal-article","created":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T02:47:17Z","timestamp":1741747637000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Elevated serum CD40 as a potential biomarker for the differential diagnosis of acute thyrotoxic myopathy"],"prefix":"10.1038","volume":"15","author":[{"given":"Chunjiao","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingliang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiyu","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyi","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuojie","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,12]]},"reference":[{"key":"93522_CR1","doi-asserted-by":"publisher","unstructured":"Boddu, N. J., Badireddi, S., Straub, K. D., Schwankhaus, J. & Jagana, R. Acute thyrotoxic bulbar myopathy with encephalopathic behaviour: An uncommon complication of hyperthyroidism. Case Rep. Endocrinol. 2013, 369807. https:\/\/doi.org\/10.1155\/2013\/369807 (2013).","DOI":"10.1155\/2013\/369807"},{"key":"93522_CR2","first-page":"896","volume":"28","author":"H Zhou","year":"2012","unstructured":"Zhou, H. et al. Clinicial analysis of 69 patients with acute hyperthyroid myopathy and its treatment. Chin. J. Endocr. Metab. 28, 896 (2012).","journal-title":"Chin. J. Endocr. Metab."},{"key":"93522_CR3","doi-asserted-by":"publisher","unstructured":"Wagner, A. H., Klersy, A., Sultan, C. S. & Hecker, M. Potential role of soluble CD40 receptor in chronic inflammatory diseases. Biochem. Pharmacol. 217. https:\/\/doi.org\/10.1016\/j.bcp.2023.115858 (2023).","DOI":"10.1016\/j.bcp.2023.115858"},{"key":"93522_CR4","doi-asserted-by":"publisher","first-page":"759597","DOI":"10.3389\/fendo.2021.759597","volume":"12","author":"H Jiang","year":"2021","unstructured":"Jiang, H. et al. Compelling evidence linking CD40 gene with graves\u2019 disease in the Chinese Han population. Front. Endocrinol. 12, 759597. https:\/\/doi.org\/10.3389\/fendo.2021.759597 (2021).","journal-title":"Front. Endocrinol."},{"key":"93522_CR5","first-page":"427","volume":"44","author":"SE Fu","year":"2023","unstructured":"Fu, S. E. et al. Acute thyrotoxic myopathy combined with neck pain: A case report. Neuroendocrinol. Lett. 44, 427\u2013431 (2023).","journal-title":"Neuroendocrinol. Lett."},{"key":"93522_CR6","first-page":"386","volume":"59","author":"B Mathew","year":"2011","unstructured":"Mathew, B., Devasia, A. J., Ayyar, V., Thyagaraj, V. & Francis, G. A. Thyrotoxicosis presenting as acute bulbar palsy. J. Assoc. Phys. India 59, 386\u2013387 (2011).","journal-title":"J. Assoc. Phys. India"},{"key":"93522_CR7","doi-asserted-by":"publisher","unstructured":"Kahaly, G. J. et al. A novel Anti-CD40 monoclonal antibody, Iscalimab, for control of graves Hyperthyroidism-A Proof-of-Concept trial. J. Clin. Endocrinol. Metab. 105. https:\/\/doi.org\/10.1210\/clinem\/dgz013 (2020).","DOI":"10.1210\/clinem\/dgz013"},{"key":"93522_CR8","doi-asserted-by":"publisher","first-page":"24364","DOI":"10.1038\/s41598-024-76273-5","volume":"14","author":"SE Fu","year":"2024","unstructured":"Fu, S. E. et al. Chronic thyrotoxic myopathy development is associated with thyroid hormone sensitivity index, predicted by lower-limb fatigue and the squat-up test. Sci. Rep. 14, 24364. https:\/\/doi.org\/10.1038\/s41598-024-76273-5 (2024).","journal-title":"Sci. Rep."},{"key":"93522_CR9","doi-asserted-by":"publisher","unstructured":"Ali, A., Mostafa, W., Fernandez, C., Ahmad, H. & Htwe, N. Apathetic thyroid storm with cardiorespiratory failure, pulmonary embolism, and coagulopathy in a young male with graves\u2019 disease and myopathy. Case Rep. Endocrinol. 8896777. https:\/\/doi.org\/10.1155\/2020\/8896777 (2020).","DOI":"10.1155\/2020\/8896777"},{"key":"93522_CR10","doi-asserted-by":"publisher","first-page":"472","DOI":"10.2169\/internalmedicine.39.472","volume":"39","author":"H Noto","year":"2000","unstructured":"Noto, H., Mitsuhashi, T., Ishibashi, S. & Kimura, S. Hyperthyroidism presenting as dysphagia. Int. Med. 39, 472\u2013473. https:\/\/doi.org\/10.2169\/internalmedicine.39.472 (2000).","journal-title":"Int. Med."},{"key":"93522_CR11","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.2169\/internalmedicine.48.2202","volume":"48","author":"H Okada","year":"2009","unstructured":"Okada, H. & Yoshioka, K. Thyrotoxicosis complicated with dysphagia. Int. Med. 48, 1243\u20131245. https:\/\/doi.org\/10.2169\/internalmedicine.48.2202 (2009).","journal-title":"Int. Med."},{"key":"93522_CR12","doi-asserted-by":"publisher","unstructured":"Alwithenani, R., Andrade, D. M., Zhang, L. & Gomez-Hernandez, K. E. Myopathic dysphagia caused by thyrotoxicosis: A case report and review of the literature. Endocrinol. Diabetes Metab. Case Rep. https:\/\/doi.org\/10.1530\/edm-21-0175 (2022).","DOI":"10.1530\/edm-21-0175"},{"key":"93522_CR13","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1007\/s12098-021-03870-x","volume":"88","author":"R Rajendiran","year":"2021","unstructured":"Rajendiran, R. et al. Thyrotoxic dysphagia in a child. Indian J. Pediatr. 88, 1046. https:\/\/doi.org\/10.1007\/s12098-021-03870-x (2021).","journal-title":"Indian J. Pediatr."},{"key":"93522_CR14","doi-asserted-by":"publisher","first-page":"829411","DOI":"10.3389\/fendo.2022.829411","volume":"13","author":"Y Li","year":"2022","unstructured":"Li, Y. et al. The Resting-State brain network functional connectivity changes in patients with acute thyrotoxic myopathy based on independent component analysis. Front. Endocrinol. 13, 829411. https:\/\/doi.org\/10.3389\/fendo.2022.829411 (2022).","journal-title":"Front. Endocrinol."},{"key":"93522_CR15","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1177\/02841851241280115","volume":"65","author":"Y Kuang","year":"2024","unstructured":"Kuang, Y. et al. Abnormal brain regional activity in acute thyrotoxic myopathy assessed by resting-state functional MRI. Acta Radiol. 65, 1347\u20131358. https:\/\/doi.org\/10.1177\/02841851241280115 (2024).","journal-title":"Acta Radiol."},{"key":"93522_CR16","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/s41582-019-0227-8","volume":"15","author":"NE Gilhus","year":"2019","unstructured":"Gilhus, N. E. & Deuschl, G. Neuroinflammation\u2014a common thread in neurological disorders. Nat. Rev. Neurol. 15, 429\u2013430. https:\/\/doi.org\/10.1038\/s41582-019-0227-8 (2019).","journal-title":"Nat. Rev. Neurol."},{"key":"93522_CR17","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.cytogfr.2023.11.002","volume":"75","author":"Y Zhou","year":"2024","unstructured":"Zhou, Y., Richmond, A. & Yan, C. Harnessing the potential of CD40 agonism in cancer therapy. Cytokine Growth Factor Rev. 75, 40\u201356. https:\/\/doi.org\/10.1016\/j.cytogfr.2023.11.002 (2024).","journal-title":"Cytokine Growth Factor Rev."},{"key":"93522_CR18","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1080\/1744666x.2018.1485492","volume":"14","author":"K Jobling","year":"2018","unstructured":"Jobling, K. & Ng, W. F. CD40 as a therapeutic target in Sj\u00f6gren\u2019s syndrome. Expert Rev. Clin. Immunol. 14, 535\u2013537. https:\/\/doi.org\/10.1080\/1744666x.2018.1485492 (2018).","journal-title":"Expert Rev. Clin. Immunol."},{"key":"93522_CR19","doi-asserted-by":"publisher","unstructured":"Wangriatisak, K. et al. CD4(+) T-cell Cooperation promoted pathogenic function of activated Na\u00efve B cells of patients with SLE. Lupus Sci. Med. 9. https:\/\/doi.org\/10.1136\/lupus-2022-000739 (2022).","DOI":"10.1136\/lupus-2022-000739"},{"key":"93522_CR20","doi-asserted-by":"publisher","first-page":"3771","DOI":"10.1210\/en.2016-1304","volume":"157","author":"GE G\u00f6rtz","year":"2016","unstructured":"G\u00f6rtz, G. E. et al. Pathogenic phenotype of adipogenesis and hyaluronan in orbital fibroblasts from female graves\u2019 orbitopathy mouse model. Endocrinology 157, 3771\u20133778. https:\/\/doi.org\/10.1210\/en.2016-1304 (2016).","journal-title":"Endocrinology"},{"key":"93522_CR21","doi-asserted-by":"publisher","unstructured":"Daub, S., Lutgens, E., M\u00fcnzel, T. & Daiber, A. CD40\/CD40L and related signaling pathways in cardiovascular health and Disease-The pros and cons for cardioprotection. Int. J. Mol. Sci. 21. https:\/\/doi.org\/10.3390\/ijms21228533 (2020).","DOI":"10.3390\/ijms21228533"},{"key":"93522_CR22","doi-asserted-by":"publisher","unstructured":"Ots, H. D., Tracz, J. A., Vinokuroff, K. E. & Musto, A. E. CD40-CD40L in neurological disease. Int. J. Mol. Sci. 23. https:\/\/doi.org\/10.3390\/ijms23084115 (2022).","DOI":"10.3390\/ijms23084115"},{"key":"93522_CR23","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.3324\/haematol.2022.281482","volume":"108","author":"ME Reiche","year":"2023","unstructured":"Reiche, M. E. et al. Adipocytes control hematopoiesis and inflammation through CD40 signaling. Haematologica 108, 1873\u20131885. https:\/\/doi.org\/10.3324\/haematol.2022.281482 (2023).","journal-title":"Haematologica"},{"key":"93522_CR24","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/s2213-8587(19)30059-2","volume":"7","author":"OE Okosieme","year":"2019","unstructured":"Okosieme, O. E. et al. Primary therapy of graves\u2019 disease and cardiovascular morbidity and mortality: A linked-record cohort study. Lancet Diabets Endocrionol. 7, 278\u2013287. https:\/\/doi.org\/10.1016\/s2213-8587(19)30059-2 (2019).","journal-title":"Lancet Diabets Endocrionol."},{"key":"93522_CR25","doi-asserted-by":"publisher","first-page":"197","DOI":"10.4274\/jcrpe.galenos.2019.2019.0108","volume":"12","author":"KA Metwalley","year":"2020","unstructured":"Metwalley, K. A., Farghaly, H. S., Raafat, D. M., Ismail, A. M. & Saied, G. M. Soluble CD40 ligand levels in children with newly diagnosed graves\u2019 disease. J. Clin. Res. Pediatr. Endocrinol. 12, 197\u2013201. https:\/\/doi.org\/10.4274\/jcrpe.galenos.2019.2019.0108 (2020).","journal-title":"J. Clin. Res. Pediatr. Endocrinol."},{"key":"93522_CR26","doi-asserted-by":"publisher","first-page":"15","DOI":"10.24425\/fmc.2020.135010","volume":"60","author":"M Minasyan","year":"2020","unstructured":"Minasyan, M. et al. fT3:fT4 ratio in graves\u2019 disease\u2014correlation with trab level, goiter size and age of onset. Folia Med. Cracov. 60, 15\u201327. https:\/\/doi.org\/10.24425\/fmc.2020.135010 (2020).","journal-title":"Folia Med. Cracov."},{"key":"93522_CR27","doi-asserted-by":"publisher","first-page":"713475","DOI":"10.3389\/fendo.2021.713475","volume":"12","author":"Y Min","year":"2021","unstructured":"Min, Y. et al. Preoperatively predicting the central lymph node metastasis for papillary thyroid Cancer patients with Hashimoto\u2019s thyroiditis. Front. Endocrinol. 12, 713475. https:\/\/doi.org\/10.3389\/fendo.2021.713475 (2021).","journal-title":"Front. Endocrinol."},{"key":"93522_CR28","doi-asserted-by":"publisher","first-page":"153303382211276","DOI":"10.1177\/15330338221127605","volume":"21","author":"X Wu","year":"2022","unstructured":"Wu, X. et al. Predictive value of FNA-Tg and TgAb in cervical lymph node metastasis of papillary thyroid carcinoma. Technol. Cancer Res. Treat. 21, 15330338221127605. https:\/\/doi.org\/10.1177\/15330338221127605 (2022).","journal-title":"Technol. Cancer Res. Treat."},{"key":"93522_CR29","doi-asserted-by":"publisher","first-page":"1354426","DOI":"10.3389\/fendo.2024.1354426","volume":"15","author":"Y Zhao","year":"2024","unstructured":"Zhao, Y. et al. Prognostic value of postoperative anti-thyroglobulin antibody in patients with differentiated thyroid cancer. Front. Endocrinol. 15, 1354426. https:\/\/doi.org\/10.3389\/fendo.2024.1354426 (2024).","journal-title":"Front. Endocrinol."},{"key":"93522_CR30","doi-asserted-by":"publisher","first-page":"598836","DOI":"10.3389\/fendo.2020.598836","volume":"11","author":"X Zhang","year":"2020","unstructured":"Zhang, X. et al. The role of thyroid hormones and autoantibodies in metabolic dysfunction associated fatty liver disease: TgAb May be a potential protective factor. Front. Endocrinol. 11, 598836. https:\/\/doi.org\/10.3389\/fendo.2020.598836 (2020).","journal-title":"Front. Endocrinol."},{"key":"93522_CR31","doi-asserted-by":"publisher","unstructured":"Ross, D. S. et al. American Thyroid Association Guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid 26, 1343\u20131421. https:\/\/doi.org\/10.1089\/thy.2016.0229 (2016).","DOI":"10.1089\/thy.2016.0229"},{"key":"93522_CR32","unstructured":"Zhou, H. Y., Liang, X. H., Qin, S. Z., Qin, Y. F., Zhou, J., Zhang J. & Luo, Z. J. In The 11th National Endocrinology Academic Conference of the Chinese Medical Association: Proceedings 109\u2013109 (Chinese Medical Association)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-93522-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-93522-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-93522-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T14:28:34Z","timestamp":1741789714000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-93522-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,12]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["93522"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-93522-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,12]]},"assertion":[{"value":"4 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study is retrospective in nature, with all data anonymized to exclude any personally identifiable information, thereby waiving the requirement for patient informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The study was conducted according to the guidelines of the Declaration of Helsinki. This study was conducted with the approval of the Ethics Committee of the First Affiliated Hospital of Guangxi Medical University, under the ethical review number 2024-E779-01.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board statement"}}],"article-number":"8467"}}